Understanding Sepsis-Associated Acute Kidney Injury
Author Information
Author(s): Kounatidis Dimitris, Tzivaki Ilektra, Daskalopoulou Stavroula, Daskou Anna, Adamou Andreas, Rigatou Anastasia, Sdogkos Evangelos, Karampela Irene, Dalamaga Maria, Vallianou Natalia G.
Primary Institution: National and Kapodistrian University of Athens
Hypothesis
The review aims to elucidate the pathophysiological pathways implicated in sepsis-associated acute kidney injury (SA-AKI) and its diagnostics and therapeutics.
Conclusion
Sepsis-associated acute kidney injury is a significant condition that requires early recognition and targeted therapeutic interventions to improve patient outcomes.
Supporting Evidence
- SA-AKI is associated with increased mortality compared to sepsis or AKI alone.
- Timely recognition of SA-AKI is crucial for improving morbidity and mortality rates.
- Urinary biomarkers like NGAL and cystatin C can detect AKI earlier than serum creatinine levels.
- Machine learning models show promise in predicting SA-AKI and associated mortality.
Takeaway
Sepsis can hurt your kidneys, and doctors are trying to find better ways to spot and treat this problem early.
Methodology
This is a review article discussing various biomarkers and therapeutic options for SA-AKI.
Limitations
The review highlights the need for further research on the specificity of urinary biomarkers for SA-AKI.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website